AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Exemestane and aromatase inhibitors play role in breast cancer management.
2004 APR 21 - (NewsRx.com & NewsRx.net) -- Exemestane and aromatase inhibitors play a role in the management of advanced breast cancer.
"In metastatic breast cancer, orally-active, potent, selective third-generation nonsteroidal inhibitors and steroidal inactivators have shown superiority over tamoxifen, a selective estrogen receptor modulator. In advanced breast cancer, aromatase inhibitors and inactivators are becoming established as the standard of care over tamoxifen in postmenopausal female breast cancer patients when hormonal therapy is indicated for first-line treatment. Emerging research evidence and ongoing clinical investigations look likely to further extend the use of these potent agents across several additional treatment settings in the management of breast cancer," scientists in Scotland report.
"Several multi-center studies are underway examining the role of novel hormonal therapy in the adjuvant treatment of early breast cancer and other investigations will explore possible future ...
- Aromatase Inhibitors Declared Superior to Tamoxifen in the Adjuvant Treatment...
- Press release article from: PR Newswire August 1, 2006 700+ words
...panel of breast cancer specialists...value of aromatase inhibitors such as ARIMIDEX...of leading breast cancer specialists...agreed that aromatase inhibitors (AIs) surpass...the use of aromatase inhibitors in early breast cancer, and while...
- Aromatase inhibitors improve breast cancer survival.(cancer treatments)(Brief...
- Magazine article from: Focus on Healthy Aging December 1, 2006 700+ words
Score another win for the class of breast cancer drugs known as the aromatase inhibitors. A study in the September 20 Journal of...significantly improve survival in women with advanced breast cancer compared with the standard drug, tamoxifen...
- New breast cancer drug.(aromatase inhibitors)(Brief Article)
- Magazine article from: U.S. News & World Report Brink, Susan December 24, 2001 700+ words
...menopausal women with breast cancer more than tamoxifen...new drugs, called aromatase inhibitors, block fat cells...fuels the growth of breast cancer cells. But this...with early-stage breast cancer who took one of the...
- Watch for poor bone health after breast cancer.(Women's Health)(Aromatase...
- Magazine article from: Internal Medicine News Palkhivala, Alison October 15, 2007 700+ words
...MONTREAL -- Aromatase inhibitors can wreak...treated for breast cancer, Dr. Eugene...chemotherapy for breast cancer has been associated...closely by aromatase inhibitors (AIs...for early breast cancer, replacing...
- Endocrine-responsive breast cancer in the elderly: role of aromatase...
- Magazine article from: Advances in Oncology Aapro, Matti March 1, 2009 700+ words
...including aromatase inhibitors, is important...patients with breast cancer who frequently...the data on aromatase inhibitors, including...sensitive breast cancer, whether...trials of the aromatase inhibitors, evidence...
- Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in...
- Press release article from: PR Newswire December 13, 2008 700+ words
...early stage breast cancer. In this...wide use of aromatase inhibitors for adjuvant...positive breast cancer. "Our multivariate...treated with aromatase inhibitors. In addition...Oncotype DX breast cancer assay by studying...
- Aromatase inhibitors constitute new endocrine therapy for breast cancer.
- Newspaper article from: Biotech Week June 9, 2004 700+ words
...net) -- Aromatase inhibitors constitute...therapy for breast cancer. "Estrogens...dependent breast cancer," researchers...Competitive aromatase inhibitors are molecules...Medicine (Aromatase inhibitors: New endocrine...treatment of breast ...
- Research and Markets: Aromatase Inhibitors in Breast Cancer:.
- Press release article from: Business Wire May 6, 2004 700+ words
...announced the addition of Aromatase Inhibitors in Breast Cancer to their offering...the world market for aromatase inhibitors was valued at $420...the market soon. Aromatase Inhibitors in Breast Cancer is a timely strategic...
Source: HighBeam Research, Exemestane and aromatase inhibitors play role in breast cancer...